Rocket Pharmaceuticals Warrant
RCKTW
15 hedge funds and large institutions have $2.01M invested in Rocket Pharmaceuticals Warrant in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
7% more funds holding
Funds holding: 14 → 15 (+1)
0.85% more ownership
Funds ownership: 2.79% → 3.64% (+0.85%)
16% less capital invested
Capital invested by funds: $2.38M → $2.01M (-$372K)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Altium Capital Management
New York
|
+$232K |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$20.4K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$31 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Skaana Management
Brooklyn,
New York
|
-$11.4K |
| 2 |
CAC
Cowen and Company
New York
|
-$823 |
| 3 |
Walleye Capital
New York
|
-$5 |
RCKTW Hedge Fund Activity: Q1 2024 in Review
15 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Rocket Pharmaceuticals Warrant (RCKTW) for Q1 2024, worth a combined $2.01M — down 16% from $2.38M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new RCKTW positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Altium Capital Management, opening a new position worth an estimated $232K. The largest seller was Skaana Management, exiting entirely with an estimated $11.4K sold.
- 15 institutional investors held Rocket Pharmaceuticals Warrant (RCKTW) as of Q1 2024, up from 14 in Q4 2023.
- Funds reported $2.01M of Rocket Pharmaceuticals Warrant stock for Q1 2024, down 16% quarter-over-quarter.
- 2 funds opened new Rocket Pharmaceuticals Warrant positions in Q1 2024 and 1 closed out, a net change of +1 holder.
- The largest Rocket Pharmaceuticals Warrant buyer in Q1 2024 was Altium Capital Management, an estimated $232K added.
- The largest Rocket Pharmaceuticals Warrant seller in Q1 2024 was Skaana Management, an estimated $11.4K sold.
Based on aggregated 13F filings for Q1 2024.